Michelle Kirschner’s Post

Join me this Thursday to learn more about the basics of lymphedema therapy!

🎗️ March is Myeloma Action Month! 🎗️ This March, we at Excerpta Medica proudly support Myeloma Action Month, a crucial global initiative aimed at raising awareness about multiple myeloma, an often overlooked and misunderstood form of blood cancer. As a medical communications agency committed to elevating healthcare knowledge, we understand the power of information in transforming lives. Multiple myeloma affects plasma cells in the bone marrow, leading to a range of symptoms that can impact a person’s quality of life. Early diagnosis and treatment are key to improving outcomes, yet awareness remains low. We stand in solidarity with patients, caregivers, and healthcare professionals worldwide. By spreading knowledge and encouraging open conversations, we can empower those affected by multiple myeloma to seek the care they need and deserve. Together, we can make a difference. #MYelomaACTIONMonth #MultipleMyelomaAwareness #ExcerptaMedica #MedicalAwareness #GoodAloneGreatTogether #medcomms

🎉 CodeX's inaugural use case, EHR Endpoints for Cancer Clinical Trials, better known as ICAREdata, is coming to a successful close. Starting in 2018, the use case sought to use mCODE (minimal Common Oncology Data Elements) to collect, extract, and transmit key outcome data for clinical research. ICAREdata demonstrated the feasibility of using real-world data in multi-institutional cancer clinical trials.   📅 Join us at the CodeX Community of Practice, December 13 at 12pm ET to learn about ICAREdata's successes and lessons learned. Register here: https://lnkd.in/gKJrnSr6   ⭐️ CodeX continues exploring how real-world data can transform clinical trials in our newest use case, Data-DIRECT. Reach out to learn more!   #RealWorldData #ClinicalResearch

Virtual Forum: Post-ASH Updates. Join us for an insightful virtual forum where we delve into the latest updates from the American Society of Hematology (ASH). Our esteemed speakers include: Professor Claire Harrison from Guy’s & St Thomas’ Hospital, London Dr. Bethan Psaila from the University of Oxford Dr. Jonathan Lambert from UCLH London About ASH: With over 18,000 members spanning nearly 100 countries, ASH stands as the world’s largest professional society, uniting clinicians and scientists in their tireless efforts to combat blood diseases. Event Details: Date: Friday, March 8, 2024 Time: 4:30 PM – 6:00 PM (GMT) Location: Online (via Zoom) How to Participate: Register: Secure your spot by registering for the virtual forum via this link https://linktr.ee/Mpnvoice Once registered, you’ll receive an email with the Zoom link. On-Demand Video: Can’t make it? Don’t worry! An on-demand video of the full event will be available on the MPN Voice YouTube channel after the forum. Q&A Session: During the live session, our panel will address questions from the audience. You can submit your questions in advance via the registration form or by emailing info@mpnvoice.org.uk. On the day, feel free to participate in the meeting chat facility. Please note that while our team won’t provide individual medical advice, they’ll gladly tackle general inquiries. Unanswered Questions: In case we can’t cover all submitted questions during the session, rest assured that our team will follow up via email. Let’s come together virtually to stay informed and connected! #bloodcancer

We at Isotopia are proud to support "Movember", a global movement dedicated to raising awareness of men's health, focusing on such vital issues as prostate cancer, testicular cancer, and mental health. As leaders in the field of theranostics, we are committed to advancing innovative radiopharmaceuticals, offering cutting-edge diagnostic and therapeutic tools that help men in their fight against prostate cancer. This month, we invite our team, partners, and community to get involved—whether by growing a mustache, raising awareness, or simply sparking important conversations about men’s health. Together, we have the power to make a meaningful impact and support the well-being of the men we care about. #Movember #MensHealth #ProstateCancerAwareness #TesticularCancerAwareness #Isotopia #Theranostics #NuclearMedicine

Lung cancer remains the most significant factor in cancer mortality worldwide, and every year, the most recent innovations and breakthroughs in lung cancer medicine will be reported at the World Conference on Lung Cancer (WCLC). WCLC 2024 will take place from 7-10 September in San Diego, USA. As last year, MemoInOncology will provide interesting articles, interviews with top experts in the field, and a comprehensive report on some of the most significant contributions made at the conference. #WCLC2024 #Lungcancer

5 Lessons I’ve Learned in the Last Decade as a BRCA2 Previvor and Professor 1. Information is powerful, but more information isn’t always better. We need to find trustworthy and credible information about cancer prevention and treatment but also about psychosocial aspects of living with hereditary cancer. 2. Information changes. We live in an era of evolving cancer information. As a researcher, this is encouraging because it means we are identifying new treatments and mechanisms for improving and saving lives. As a patient, this means I must continually reassess and talk to my clinicians. 3. We must actively participate in our medical encounters. We ask questions even when we are embarrassed. We bring information to our appointments even when we found them online. We talk to our doctors to make sure we understand how information relates to our lives. 4. Emotions are a part of a journey with hereditary cancer. Not only must we manage our own emotions, but our family members’ emotions may also influence us at times. We don’t always know what someone is going through, so we cut our family members slack. 5. Sharing genetic risk information is not a “one and done conversation.” Effective communication about hereditary cancer with family members requires multiple conversations over years. While we can’t control how our family members react, we can share information in stages to help reduce information overload and to help continue our relationships. #HereditaryCancer #BRCA #Previvor #NHCW #NationalHereditaryCancerWeek

Chances are, you know someone who has faced the tough battle with cancer. But the good news is that everyday choices, from what we eat to how we handle stress, can significantly impact our chances of preventing this health challenge and catching it early. In this two-part blog, we sit down with VSMG’s Clinical Advisor of Health & Wellness Services, Dr. Lauren Bachman, DNP, AGNP-BC, IFMCP, to talk about her extensive experience in the fields of oncology and hematology, followed by nine practical tips to help you live your healthiest, most vibrant life.

🎙 Breathing easy: deciphering RA-ILD with the VARA registry ➡ Join Barbara and @Juge_P_A and hear from Dr. Bryant England, Associate Professor of the University of Nebraska, who is looking into RA-ILD in the Veterans Affairs RA registry! 🔎 Get ready to dive deep into his research to predict lung cancer risks in patients with RA-ILD. And that's not all! 🎧: https://lnkd.in/e2bhnvaj

By prioritizing patient-centered care and fostering ongoing research, we can collectively transform #cancer survivorship and empower individuals to lead fulfilling lives beyond their diagnosis. Awny Farajallah, MD, FACP, Chief Medical Officer, Global Oncology, explains how the future of cancer care is rooted in prioritizing an individual's overall well-being. Read more: https://lnkd.in/gsVnpzu5